Global Custom Market Research Reports Provider Company


UMN Pharma Inc. (4585) - Financial and Strategic SWOT Analysis Review

  • Published Date: 01 Feb 2015
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: Japan


UMN Pharma Inc. (UMN) is a biopharmaceutical company. The company develops vaccines to cure diabetes, muscular dystrophy and influenza. Its products include UMN-0502, UMN-0501, UMN-0901 and UMN-2003. UMN’s UMN-0502 is seasonal influenza vaccine. The company’s UMN-0501 and UMN-0901 are pandemic influenza vaccines. The company offers UMN-2003 product, a norovirus VLP + rotavirus VP6 non-live injectable trivalent vaccine, for the prevention of two major causative agents of acute gastroenteritis in one injection. It partners with IHI Corporation, API Co., Ltd., Protein Sciences Corporation, Astellas Pharma Inc., ILDONG Pharmaceutical Co., Ltd., University of Tampere, Catalent and Yakult Honsha. UMN is headquartered in Yokohama, Kanagawa, Japan.

This comprehensive SWOT profile of UMN Pharma Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of UMN Pharma Inc. including: and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief Summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Publisher Name : GlobalData

Section 1 - About the Company

UMN Pharma Inc. - Key Information
UMN Pharma Inc. - Overview
UMN Pharma Inc. - Key Employees
UMN Pharma Inc. - Key Employee Biographies
UMN Pharma Inc. - Key Operational Heads
UMN Pharma Inc. - Major Products and Services
UMN Pharma Inc. - History
UMN Pharma Inc. - Company Statement
UMN Pharma Inc. - Locations And Subsidiaries
UMN Pharma Inc. - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

UMN Pharma Inc. - Business Description
UMN Pharma Inc. - Corporate Strategy
UMN Pharma Inc. - SWOT Analysis
SWOT Analysis - Overview
UMN Pharma Inc. - Strengths
UMN Pharma Inc. - Weaknesses
UMN Pharma Inc. - Opportunities
UMN Pharma Inc. - Threats
UMN Pharma Inc. - Key Competitors

Section 3 - Company Financial Performance Charts

UMN Pharma Inc. - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

UMN Pharma Inc., Key Information
UMN Pharma Inc., Key Ratios
UMN Pharma Inc., Share Data
UMN Pharma Inc., Major Products and Services
UMN Pharma Inc., History
UMN Pharma Inc., Key Employees
UMN Pharma Inc., Key Employee Biographies
UMN Pharma Inc., Key Operational Heads
UMN Pharma Inc., Other Locations
UMN Pharma Inc., Subsidiaries
UMN Pharma Inc., Key Manufacturing facilities
UMN Pharma Inc., Key Competitors
UMN Pharma Inc., SWOT Analysis
UMN Pharma Inc., Ratios based on current share price
UMN Pharma Inc., Annual Ratios
UMN Pharma Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

UMN Pharma Inc., Performance Chart
UMN Pharma Inc., Ratio Charts

This report studies Polyalumnium Chloride (PAC) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions,

View Report

UMN Pharma Inc (UMN) is a biopharmaceutical company that manufactures therapeutic for diabetes, muscular dystrophy and influenza. The companys products include UMN-0502, UMN-0501, UMN-0901, UMN-2003 and UMN-2002. Its UMN-0502 is

View Report

In this report, the global Steering Columns Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports